Cargando...

WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.

The therapeutic efficacy of an experimental antiviral agent, WIN 54954, was evaluated in a mouse model in which infection by coxsackievirus B4 (CVB4) strain E2 was followed by diabetes mellitus. Male CD1 mice (age, 5 weeks) were inoculated with 10(4) PFU of CVB4. WIN 54954 was administered orally vi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: See, D M, Tilles, J G
Formato: Artigo
Lenguaje:Inglês
Publicado: 1993
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC188025/
https://ncbi.nlm.nih.gov/pubmed/8215268
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!